| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/05/2008 | CN101137437A Basic ionic liquids |
| 03/04/2008 | US7338978 Insecticidal anthranilamides |
| 03/04/2008 | US7338960 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 03/04/2008 | US7338951 N-{2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-4-yl}-N'-(1 H-indol-3-ylmethylene)-hydrazine; interleukin IL-12 overproduction-related disorder; antiinflammatory agent; autoimmune diseases: multiple sclerosis, sepsis, neuropathies, cirrhosis, hepatitis, diabetes, arthritis |
| 03/04/2008 | US7338950 Amide compounds as ion channel ligands and uses thereof |
| 02/28/2008 | WO2008024963A1 Benzene, pyridine, and pyridazine derivatives |
| 02/28/2008 | WO2008024953A2 Transition metal-catalyzed alkylation of c-h bonds with organoboron reagents |
| 02/28/2008 | WO2008024746A1 4-substituted phenoxyphenylacetic acid derivatives |
| 02/28/2008 | WO2008024304A2 Compounds for treatment of proliferative disorders |
| 02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023205A1 Process for the manufacture of hi-6 dimethanesulfonate |
| 02/28/2008 | WO2008023171A2 Ionic additive for catalysis in biphasic reaction systems |
| 02/28/2008 | WO2008022938A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | WO2008022467A1 2-substituted azain doles and 2 substituted thienopyrroles, their precursors and novel processes for the preparation thereof |
| 02/28/2008 | WO2008003744A3 N-methyl benzamide derivatives useful as fungicides |
| 02/28/2008 | WO2008002868A3 Pyridinium salts for polymer composites and methods for their preparation |
| 02/28/2008 | WO2007017510A3 Isophthalic acid diamides for treating alzheimer's disease |
| 02/28/2008 | WO2007016136A3 Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and methods of use |
| 02/28/2008 | US20080051446 Heterocyclocarboxamide Derivatives |
| 02/28/2008 | US20080051418 Arylalkanoic Acid Derivative |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 02/28/2008 | US20080050604 Polymer Light-Emitting Material and Organic Light Emitting Element |
| 02/28/2008 | DE202004021443U1 Verpackung für eine Spüle Packing for a sink |
| 02/28/2008 | CA2697002A1 Ionic additive for catalysis in biphasic reaction systems |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/28/2008 | CA2661459A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | CA2661440A1 Compounds for treating proliferative disorders |
| 02/28/2008 | CA2661316A1 Process for the manufacture of hi-6 dimethanesulfonate |
| 02/28/2008 | CA2661164A1 4-substituted phenoxyphenylacetic acid derivatives |
| 02/28/2008 | CA2660531A1 Compounds for treatment of proliferative disorders |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1891028A1 Non-peptidic inhibitors of akap/pka interaction |
| 02/27/2008 | EP1890697A2 Azinone and diazinone v3 inhibitors for depression and stress disorders |
| 02/27/2008 | EP1778627B1 Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives |
| 02/27/2008 | EP1740530A4 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 02/27/2008 | EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors |
| 02/27/2008 | EP1483266B1 Spiro compounds with npy antagonistic activity |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1399423B9 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 02/27/2008 | EP1351685B1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133042A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133027A Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 02/27/2008 | CN101133019A Derivatives of aminobutanoic acid inhibiting cpt |
| 02/27/2008 | CN101130526A Aryl carbonyl derivatives as therapeutic agents |
| 02/27/2008 | CN101130519A Method for producing pyridylethylthio compound, method for producing modified ion-exchanger and bisphenol comound |
| 02/27/2008 | CN101130518A Ionic liquid photo generated base alkaline agent, preparing method and uses of the same |
| 02/27/2008 | CN101129365A Analgesics use of ricinine |
| 02/27/2008 | CN100371327C One-step synthesis method of 2-amido-6-alkoxy-3-nitropyridine |
| 02/27/2008 | CN100371326C New substituted pyridine or pyridine compound, their producing process and pharmaceutical composition containing them |
| 02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 02/27/2008 | CN100371075C Catalyst systems for ethylene oligomerisation to linear alpha olefins |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/26/2008 | US7335799 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X |
| 02/26/2008 | US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/26/2008 | US7335689 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335672 Vanilloid receptor ligands and their use in treatments |
| 02/26/2008 | US7335653 Bis-aryl sulfonamides |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease |
| 02/21/2008 | WO2008021836A1 Process for quenching gaseous reaction product containing cyanopyridine |
| 02/21/2008 | WO2008021388A1 Heteroaryl derivatives as cytokine inhibitors |
| 02/21/2008 | WO2008020124A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 02/21/2008 | WO2008020113A1 Luminescent lanthanide labelling reagents and their use |
| 02/21/2008 | WO2008019477A1 Viral polymerase inhibitors |
| 02/21/2008 | WO2007149448A3 Pyrazinones as cellular proliferation inhibitors |
| 02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
| 02/21/2008 | WO2007010222A3 Therapeutic agents |
| 02/21/2008 | US20080045589 Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer |
| 02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
| 02/21/2008 | US20080045545 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal |
| 02/21/2008 | US20080045533 Novel cyclohexyl sulphones |
| 02/21/2008 | US20080045521 Phenylalanine derivatives |
| 02/21/2008 | US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer |
| 02/21/2008 | US20080045516 Viral Polymerase Inhibitors |
| 02/21/2008 | US20080045461 N-terminally modified glp-1 receptor modulators |
| 02/21/2008 | US20080044923 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging; [Eu.(1-4H).H2O]Na |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/21/2008 | DE102006039003A1 Neue Verbindungen New connections |
| 02/21/2008 | CA2661093A1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 02/21/2008 | CA2660911A1 Thiourea compounds |
| 02/21/2008 | CA2660560A1 Pyrazine compounds, their use and methods of preparation |
| 02/21/2008 | CA2660555A1 Viral polymerase inhibitors |
| 02/21/2008 | CA2659928A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889837A1 VR1 vanilloid receptor antagonists with a iononic substructure |
| 02/20/2008 | EP1889836A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 02/20/2008 | EP1889831A2 Diazenedicarboxamides as inhibitors of D-alanine: D-alanine ligase (Ddl) |
| 02/20/2008 | EP1889830A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 02/20/2008 | EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888512A2 Chemical compounds |